Development of a suspension array assay in multiplex for the simultaneous measurement of serum levels of four eosinophil granule proteins

Journal of Immunological Methods

Volumn 411, Issue , 2014, Pages 11-22

  Makiya, Michelle A ^a   Herrick, Jesica A ^a   Khoury, Paneez ^a   Prussin, Calman P ^a   Nutman, Thomas B ^a   Klion, Amy D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Degranulation; ELISA; Eosinophil; Eosinophil granule proteins; Multiplex

Indexed keywords

CD69 ANTIGEN; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PEROXIDASE; EOSINOPHIL PROTEIN X; MAJOR BASIC PROTEIN; EOSINOPHIL GRANULE PROTEIN; MULTIPLEX;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; EOSINOPHILIA; EOSINOPHILIC GASTROINTESTINAL DISORDER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT PRECISION; MULTIPLEX SUSPENSION ARRAY ASSAY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RELIABILITY; SENSITIVITY ANALYSIS; ANIMAL; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DEGRANULATION; EOSINOPHIL; GASTROINTESTINAL DISEASE; IMMUNOLOGY; METHODOLOGY; MOUSE; SENSITIVITY AND SPECIFICITY;

DEGRANULATION; ELISA; EOSINOPHIL; EOSINOPHIL GRANULE PROTEINS; MULTIPLEX;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILIA; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MICE; SENSITIVITY AND SPECIFICITY;

EID: 84907060469     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.05.020     Document Type: Article

References (45)

1. Abu-Ghazaleh R.I., Dunnette S.L., Loegering D.A., Checkel J.L., Kita H., Thomas L.L., Gleich G.J. Eosinophil granule proteins in peripheral blood granulocytes. J. Leukoc. Biol. 1992, 52:611.
2. Ackerman S.J., Gleich G.J., Loegering D.A., Richardson B.A., Butterworth A.E. Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 1985, 34:735.
3. Ackerman S.J., Kephart G.M., Francis H., Awadzi K., Gleich G.J., Ottesen E.A. Eosinophil degranulation. An immunologic determinant in the pathogenesis of the Mazzotti reaction in human onchocerciasis. J. Immunol. 1990, 144:3961.
4. Bafadhel M., McCormick M., Saha S., McKenna S., Shelley M., Hargadon B., Mistry V., Reid C., Parker D., Dodson P., Jenkins M., Lloyd A., Rugman P., Newbold P., Brightling C.E. Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration 2012, 83:36.
5. Campbell J.P., Cobbold M., Wang Y., Goodall M., Bonney S.L., Chamba A., Birtwistle J., Plant T., Afzal Z., Jefferis R., Drayson M.T. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine. J. Immunol. Methods 2013, 391:1.
6. Colocho Zelaya E.A., Orvell C., Strannegard O. Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus. Pediatr. Allergy Immunol. 1994, 5:100.
7. Flood-Page P.T., Menzies-Gow A.N., Kay A.B., Robinson D.S. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am. J. Respir. Crit. Care Med. 2003, 167:199.
8. Furuta G.T., Kagalwalla A.F., Lee J.J., Alumkal P., Maybruck B.T., Fillon S., Masterson J.C., Ochkur S., Protheroe C., Moore W., Pan Z., Amsden K., Robinson Z., Capocelli K., Mukkada V., Atkins D., Fleischer D., Hosford L., Kwatia M.A., Schroeder S., Kelly C., Lovell M., Melin-Aldana H., Ackerman S.J. The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis. Gut 2013, 62:1395.
9. Gleich G.J., Schroeter A.L., Marcoux J.P., Sachs M.I., O'Connell E.J., Kohler P.F. Episodic angioedema associated with eosinophilia. N. Engl. J. Med. 1984, 310:1621.
10. Hallgren R., Terent A., Venge P. Eosinophil cationic protein (ECP) in the cerebrospinal fluid. J. Neurol. Sci. 1983, 58:57.
11. Hamann K.J., Gleich G.J., Checkel J.L., Loegering D.A., McCall J.W., Barker R.L. In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins. J. Immunol. 1990, 144:3166.
12. Karawajczyk M., Pauksen K., Peterson C.G., Eklund E., Venge P. The differential release of eosinophil granule proteins. Studies on patients with acute bacterial and viral infections. Clin. Exp. Allergy 1995, 25:713.
13. Karawajczyk M., Peterson C.G., Venge P., Garcia R.C. An extragranular compartment of blood eosinophils contains eosinophil protein X/eosinophil-derived neurotoxin (EPX/EDN). Inflammation 2013, 36:320.
14. Kato M., Ishioka T., Kita H., Kozawa K., Hayashi Y., Kimura H. Eosinophil granular proteins damage bronchial epithelial cells infected with respiratory syncytial virus. Int. Arch. Allergy Immunol. 2012, 158(Suppl. 1):11.
15. Kita H. Eosinophils: multifaceted biological properties and roles in health and disease. Immunol. Rev. 2011, 242:161.
16. Klion A.D., Law M.A., Riemenschneider W., McMaster M.L., Brown M.R., Horne M., Karp B., Robinson M., Sachdev V., Tucker E., Turner M., Nutman T.B. Familial eosinophilia: a benign disorder?. Blood 2004, 103:4050.
17. Koller D.Y., Halmerbauer G., Muller J., Frischer T., Schierl M. Major basic protein, but not eosinophil cationic protein or eosinophil protein X, is related to atopy in cystic fibrosis. Allergy 1999, 54:1094.
18. Konikoff M.R., Blanchard C., Kirby C., Buckmeier B.K., Cohen M.B., Heubi J.E., Putnam P.E., Rothenberg M.E. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. Clin. Gastroenterol. Hepatol. 2006, 4:1328.
19. Laviolette M., Gossage D.L., Gauvreau G., Leigh R., Olivenstein R., Katial R., Busse W.W., Wenzel S., Wu Y., Datta V., Kolbeck R., Molfino N.A. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. J. Allergy Clin. Immunol. 2013, 132:1086. (e5).
20. Lee Y.J., Lee H.H., Choi B.S., Jee H.M., Kim K.W., Sohn M.H., Kim K.E. Association between eosinophilic airway inflammation and persistent airflow limitation. J. Asthma 2013, 50:342-346.
21. Lonnkvist K., Hellman C., Lundahl J., Hallden G., Hedlin G. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal. J. Allergy Clin. Immunol. 2001, 107:812.
22. Malik A., Batra J.K. Antimicrobial activity of human eosinophil granule proteins: involvement in host defence against pathogens. Crit. Rev. Microbiol. 2012, 38:168.
23. Modig J., Samuelsson T., Hallgren R. The predictive and discriminative value of biologically active products of eosinophils, neutrophils and complement in bronchoalveolar lavage and blood in patients with adult respiratory distress syndrome. Resuscitation 1986, 14:121.
24. Moller J.K. Detection of Neisseria meningitidis in cerebrospinal fluid using a multiplex PCR and the Luminex detection technology. Methods Mol. Biol. 2012, 799:37.
25. Morioka J., Kurosawa M., Inamura H., Nakagami R., Mizushima Y., Chihara J., Yokoseki T., Kitamura S., Omura Y., Shibata M. Development of a novel enzyme-linked immunosorbent assay for blood and urinary eosinophil-derived neurotoxin: a preliminary study in patients with bronchial asthma. Int. Arch. Allergy Immunol. 2000, 122:49.
26. Muniz V.S., Weller P.F., Neves J.S. Eosinophil crystalloid granules: structure, function, and beyond. J. Leukoc. Biol. 2012, 92:281.
27. Nair P., Ochkur S.I., Protheroe C., Radford K., Efthimiadis A., Lee N.A., Lee J.J. Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia. Allergy 2013, 68:1177.
28. Ochkur S.I., Kim J.D., Protheroe C.A., Colbert D., Condjella R.M., Bersoux S., Helmers R.A., Moqbel R., Lacy P., Kelly E.A., Jarjour N.N., Kern R., Peters A., Schleimer R.P., Furuta G.T., Nair P., Lee J.J., Lee N.A. A sensitive high throughput ELISA for human eosinophil peroxidase: a specific assay to quantify eosinophil degranulation from patient-derived sources. J. Immunol. Methods 2012, 384:10.
29. Ott N.L., Gleich G.J., Peterson E.A., Fujisawa T., Sur S., Leiferman K.M. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction. J. Allergy Clin. Immunol. 1994, 94:120.
30. Peters M.S., Rodriguez M., Gleich G.J. Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy. Lab. Invest. 1986, 54:656.
31. Peterson C.G., Enander I., Nystrand J., Anderson A.S., Nilsson L., Venge P. Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin. Exp. Allergy 1991, 21:561.
32. Peterson C.G., Eklund E., Taha Y., Raab Y., Carlson M. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease. Am. J. Gastroenterol. 2002, 97:1755.
33. Plager D.A., Loegering D.A., Checkel J.L., Tang J., Kephart G.M., Caffes P.L., Adolphson C.R., Ohnuki L.E., Gleich G.J. Major basic protein homolog (MBP2): a specific human eosinophil marker. J. Immunol. 2006, 177:7340.
34. Pucci N., Lombardi E., Novembre E., Farina S., Bernardini R., Rossi E., Favilli T., Vierucci A. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity. J. Allergy Clin. Immunol. 2000, 105:353.
35. Reimert C.M., Minuva U., Kharazmi A., Bendtzen K. Eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Detection by enzyme-linked immunosorbent assay and purification from normal human urine. J. Immunol. Methods 1991, 141:97.
36. Reimert C.M., Venge P., Kharazmi A., Bendtzen K. Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay. J. Immunol. Methods 1991, 138:285.
37. Robinson D.S., Assoufi B., Durham S.R., Kay A.B. Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment. Clin. Exp. Allergy 1995, 25:1118.
38. Sedgwick J.B., Vrtis R.F., Jansen K.J., Kita H., Bartemes K., Busse W.W. Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. J. Allergy Clin. Immunol. 2004, 114:568.
39. Spencer L.A., Szela C.T., Perez S.A., Kirchhoffer C.L., Neves J.S., Radke A.L., Weller P.F. Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. J. Leukoc. Biol. 2009, 85:117.
40. Tomassini M., Tsicopoulos A., Tai P.C., Gruart V., Tonnel A.B., Prin L., Capron A., Capron M. Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation. J. Allergy Clin. Immunol. 1991, 88:365.
41. Torpier G., Colombel J.F., Mathieu-Chandelier C., Capron M., Dessaint J.P., Cortot A., Paris J.C., Capron A. Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein. Clin. Exp. Immunol. 1988, 74:404.
42. Virchow J.C., Holscher U., Virchow C. Sputum ECP levels correlate with parameters of airflow obstruction. Am. Rev. Respir. Dis. 1992, 146:604.
43. Wassom D.L., Loegering D.A., Solley G.O., Moore S.B., Schooley R.T., Fauci A.S., Gleich G.J. Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. J. Clin. Invest. 1981, 67:651.
44. Yamamoto H., Ninomiya H., Yoshimatsu K., Uchiyama Y., Shibasaki M., Enokihara H., Tachibana S., Abe T. Serum levels of major basic protein in patients with or without eosinophilia: measurement by enzyme-linked immunosorbent assay. Br. J. Haematol. 1994, 86:490.
45. Yang D., Chen Q., Su S.B., Zhang P., Kurosaka K., Caspi R.R., Michalek S.M., Rosenberg H.F., Zhang N., Oppenheim J.J. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J. Exp. Med. 2008, 205:79.